The Flow Cytometry Core will be an integrated and essential component of the proposed RDRCC. The flow core will support cutting edge work on rheumatic diseases and other related immune/inflammatory disorders including immune mediated lung injury, immunology of frailty, immediate hypersensitivity and bacterial and viral induced chronic disease. The overall goal is to provide cell sorting and polychromatic flow cytometry services for a range of research initiatives including complex immune phenotyping of samples from human rheumatic disorders, investigations on the antigen driven response in human disease, basic studies on the signals that influence Immune cell differentiation and function and the development of animal models of human disease. In the next five years of the RDRCC we propose the followings three aims for the Flow Cytometry core: 1. Provide RDRCC investigators access to state of the art flow cytometry instrumentation and methodology. This includes ready access to technology, expertise and training. 2. Provide a range of flow cytometric based procedures that will enhance and expand the research programs of RDRCC investigators. 3. Attract new investigators to utilize the flow core by providing a collegial environment, through targeted outreach and by providing educational opportunities for investigators at all levels

Public Health Relevance

The Flow Cytometry core with provide state of the art technology and support for cutting edge Basic and Applied Research on Rheumatic related Immune-mediated Diseases. This core will foster collaborations and assist in the development of new investigators.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-MLB (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
United States
Zip Code
Needham, Dale M; Sepulveda, Kristin A; Dinglas, Victor D et al. (2017) Core Outcome Measures for Clinical Research in Acute Respiratory Failure Survivors. An International Modified Delphi Consensus Study. Am J Respir Crit Care Med 196:1122-1130
Darrah, Erika; Kim, AeRyon; Zhang, Xi et al. (2017) Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis. J Proteome Res 16:355-365
Cappelli, Laura C; Naidoo, Jarushka; Bingham 3rd, Clifton O et al. (2017) Inflammatory arthritis due to immune checkpoint inhibitors: challenges in diagnosis and treatment. Immunotherapy 9:5-8
Pinal-Fernandez, Iago; Parks, Cassie; Werner, Jessie L et al. (2017) Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. Arthritis Care Res (Hoboken) 69:263-270
Baer, Alan N; Petri, Michelle; Sohn, Jungsan et al. (2017) Reply. Arthritis Care Res (Hoboken) 69:454
Adler, Brittany L; Albayda, Jemima; Shores, Jamie T et al. (2017) Erosive Rheumatoid Arthritis After Bilateral Hand Transplantation. Ann Intern Med 167:216-218
Cappelli, Laura C; Gutierrez, Anna Kristina; Baer, Alan N et al. (2017) Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Ann Rheum Dis 76:43-50
Albayda, Jemima; Pinal-Fernandez, Iago; Huang, Wilson et al. (2017) Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients. Arthritis Care Res (Hoboken) 69:1771-1776
Cappelli, Laura C; Shah, Ami A; Bingham 3rd, Clifton O (2017) Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology. Rheum Dis Clin North Am 43:65-78
Turnbull, Alison E; Sepulveda, Kristin A; Dinglas, Victor D et al. (2017) Core Domains for Clinical Research in Acute Respiratory Failure Survivors: An International Modified Delphi Consensus Study. Crit Care Med 45:1001-1010

Showing the most recent 10 out of 108 publications